Search by Drug Name or NDC
NDC 59627-0003-01 Avonex Pen 30 ug/.5mL Details
Avonex Pen 30 ug/.5mL
Avonex Pen is a INTRAMUSCULAR INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Biogen Inc.. The primary component is INTERFERON BETA-1A.
MedlinePlus Drug Summary
Interferon beta-1a intramuscular injection is used to treat adults with various forms of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control) including: clinically isolated syndrome (CIS; nerve symptom episodes that last at least 24 hours), relapsing-remitting forms (course of disease where symptoms flare up from time to time), or secondary progressive forms (course of disease where relapses occur more often). Interferon beta-1a is in a class of medications called immunomodulators. It works by decreasing inflammation and preventing nerve damage that may cause symptoms of multiple sclerosis.
Related Packages: 59627-0003-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Interferon Beta-1a Intramuscular Injection
Interferon beta-1a subcutaneous injection is used to treat adults with various forms of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control) including: clinically isolated syndrome (CIS; nerve symptom episodes that last at least 24 hours), relapsing-remitting forms (course of disease where symptoms flare up from time to time), or secondary progressive forms (course of disease where relapses occur more often). Interferon beta-1a is in a class of medications called immunomodulators. It works by decreasing inflammation and preventing nerve damage that may cause symptoms of multiple sclerosis.
Related Packages: 59627-0003-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Interferon Beta-1a Subcutaneous Injection
Product Information
NDC | 59627-0003 |
---|---|
Product ID | 59627-003_3ff19956-a793-4256-bff4-7f7443d7238a |
Associated GPIs | |
GCN Sequence Number | 069046 |
GCN Sequence Number Description | interferon beta-1a PEN INJCTR 30MCG/.5ML INTRAMUSC |
HIC3 | H0E |
HIC3 Description | AGENTS TO TREAT MULTIPLE SCLEROSIS |
GCN | 27479 |
HICL Sequence Number | 011253 |
HICL Sequence Number Description | INTERFERON BETA-1A |
Brand/Generic | Brand |
Proprietary Name | Avonex Pen |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Interferon Beta-1a |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INTRAMUSCULAR |
Active Ingredient Strength | 30 |
Active Ingredient Units | ug/.5mL |
Substance Name | INTERFERON BETA-1A |
Labeler Name | Biogen Inc. |
Pharmaceutical Class | Interferon beta [EPC], Interferon-beta [CS] |
DEA Schedule | n/a |
Marketing Category | BLA |
Application Number | BLA103628 |
Listing Certified Through | 2024-12-31 |
Package
NDC 59627-0003-01 (59627000301)
NDC Package Code | 59627-003-01 |
---|---|
Billing NDC | 59627000301 |
Package | 1 SYRINGE in 1 CARTON (59627-003-01) / .5 mL in 1 SYRINGE |
Marketing Start Date | 2003-05-23 |
NDC Exclude Flag | N |
Pricing Information | N/A |